MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2017 International Congress

    Screening of cognitive impairment in Huntington’s disease with the Parkinson’s Disease – Cognitive Rating Scale (PD-CRS)

    S. Martinez-Horta, A. Horta-Barba, J. Perez-Perez, J. Pagonabarraga, J. Marin-Lahoz, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore the psychometric properties of the PD-CRS as compared to two commonly used measures (the MMSE and the UHDRS Cognitive score) for detecting…
  • 2017 International Congress

    Multimodal biomarkers as predictors of cognitive decline in Parkinson’s Disease

    T. Tropea, J. Berlyand, J. McBride, J. Doshi, C. Davatzikos, L. Shaw, S. Xie, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)

    Objective: To identify a set of multimodal biomarkers to predict cognitive decline in non-demented Parkinson’s disease patients.   Background: People with Parkinson’s Disease are at high…
  • 2017 International Congress

    “Essential tremor” as a presenting symptom of neuronal intranuclear inclusion disease (NIID).

    Z. Xu, W.-Y. Yu, J. Tan, H.-Y. Lee, Q. Cheng, T. Lim (Singapore, Singapore)

    Objective: To describe a patient with late onset, sporadic NIID who had a tremor as his first complaint. Background: NIID is a rare, slowly progressive…
  • 2017 International Congress

    Plasma Biomarkers in Idiopathic Normal Pressure Hydrocephalus

    P.-W. Ko, K. Kang, S.Y. Kim, H.-W. Lee (Daegu, Republic of Korea)

    Objective: (1) To investigate the role of plasma biomarkers that is known to related to Alzheimer’s disease in INPH(2) To assess the diagnostic and prognostic…
  • 2017 International Congress

    Prospective longitudinal CSF measurements and cognitive decline in GBA-associated Parkinsonism: not Abeta or Tau but Lewy body pathology?

    S. Lerche, C. Schulte, K. Srulijes, A. Pilotto, T. Rattay, A.-K. Hauser, E. Stransky, C. Deuschle, I. Csoti, H. Zetterberg, I. Liepelt-Scarfone, T. Gasser, W. Maetzler, D. Berg, K. Brockmann (Tübingen, Germany)

    Objective: To evaluate whether concomitant Ab and Tau pathology might contribute to the prominent cognitive decline in PD_GBA. Background: A considerable proportion of idiopathic Parkinson’s…
  • 2017 International Congress

    Cerebrotendinous xanthomatosis without tendon xanthoma: a diagnostic challenge.

    S. Souki, L. Vasconcellos, M. Spitz, J. Pereira, V. Marussi, A. Carrié, P. Couvert (Rio de Janeiro, Brazil)

    Objective: To describe the case of Cerebrotendinous xanthomatosis (CTX) without tendon xanthoma, highlighting the diagnostic challenge due to its rarity, as well as the importance…
  • 2017 International Congress

    Genetic variations in Amyloid-beta1-42 clearance proteins determine onset of dementia in Parkinson’s disease and dementia with Lewy bodies

    K. Brockmann, S. Lerche, A. Apel, A.-K. Hauser, I. Liepelt Scarfone, D. Berg, T. Gasser, C. Schulte, W. Maetzler (Tübingen, Germany)

    Objective: To evaluate whether genetic variants in genes known to be associated with Abeta1-42 clearance contribute to the interval between ages at onset of parkinsonism…
  • 2016 International Congress

    Dementia in Parkinson’s disease is associated with increased diffusivity in amygdala and external capsule

    A. Umemura, T. Oeda, K. Yamamoto, M. Kohsaka, S. Tomita, K. Park, H. Sugiyama, H. Sawada (Kyoto, Japan)

    Objective: To identify which regions are associated with dementia in Parkinson's disease (PD) brains. Background: Dementia is common in advanced PD and its early development…
  • 2016 International Congress

    Chronic cerebral hypoperfusion accelerates cognitive dysfunction and microvascular impairment in the MPTP mouse model of Parkinson’s disease

    H. Tang, R. Zhu, L. Gao, K. Nie, S. Feng, Z. Duan, Y. Zhang, X. Zhao, L. Wang, J. Zhao, Z. Huang, Y. Zhang, L. Wang (Guangzhou, People's Republic of China)

    Objective: To evaluate cerebral hypoperfusion on cognitive dysfunction and related microvascular impairment in the MPTP mouse model. Background: Vascular pathology and Parkinson's disease (PD) pathology…
  • 2016 International Congress

    FYN expression is associated with regulatory region genetic variation

    L.M. Bekris, J.A. Zahratka, Y. Shao, M. Shaw, K. Todd, M. Khrestian, J.B. Leverenz (Cleveland, OH, USA)

    Objective: The hypothesis of this investigation was that FYN expression and promoter activity are significantly influenced according to genetic content. The objective of this investigation…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 39
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley